Guardforce AI Co., Ltd. has successfully completed the acquisition of MGAI Limited, a Hong Kong-based company specializing in AI-driven speech therapy and rehabilitation solutions. This strategic move significantly expands Guardforce AI’s AI revenue growth and reinforces its commitment to commercializing domain-specific AI agents across various service industries.
The acquisition of MGAI is a pivotal step for Guardforce AI, marking a transition towards a measurable, recurring revenue model for its AI Agent platform. MGAI is recognized as a pioneer in AI-driven solutions for speech therapy and rehabilitation. Its comprehensive ecosystem includes proprietary AI-supported software, cloud-based SaaS tools, professional training systems, and integrated hardware. By utilizing one of China’s most extensive domestic databases for pediatric language development, MGAI’s platform supports a broad network of hospitals, educational institutions, and healthcare professionals. To date, its subsidiary, Muyan Education, has served over 110,000 patients and maintains a registry of more than 20,000 rehabilitation specialists.
This acquisition brings several key benefits to Guardforce AI, positioning it as an emerging leader in applied AI solutions across Asia. These include deep domain expertise in child behavior and language development, access to a proven LLM-based AI application platform for speech therapy, and a clear path for cross-border growth expansion into Hong Kong, Singapore, Taiwan, and broader Southeast Asia. The market for children’s speech and language therapy in China is substantial, projected to grow from approximately $1.2 billion in 2024 to $2.14 billion by 2033, with a CAGR of 7.5 percent. Cities with populations over one million have seen an even higher CAGR of approximately 12 percent in speech therapy service utilization.
MGAI has established revenue targets under an agreed performance framework: $0.5 million in 2026, $1 million in 2027, and $1.5 million in 2028. These projections are based on anticipated expansion of AI-enabled services, cross-border market penetration, and digital scaling of rehabilitation expertise. The transaction consideration involved $300,000 in cash and 5 million restricted ordinary shares of Guardforce AI, with the shares subject to performance-based vesting tied to revenue milestones through 2028. This structure aims to minimize upfront cash outlay while aligning long-term value creation with operational execution.